MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.
Explore the role of genetic testing in diagnosing AHDC1-related syndrome, offering early detection, personalized care, and insights for family planning and research.
Explore how genetic testing revolutionizes diagnosing Aicardi-Goutières Syndrome 7, offering precise identification, guiding treatments, and supporting family planning.
Unlock clarity on Alacrima, Achalasia, and Intellectual Disability Syndrome with genetic testing, ensuring accurate diagnosis, personalized care, and informed family planning.
Explore how genetic testing uncovers mutations in aldosterone-producing adenoma, aiding diagnosis, treatment, and management of this complex condition with neurological…
Unlock the potential of genetic testing in diagnosing Alzheimer Disease 18, a rare hereditary condition, and explore promising antiviral therapies for treatment.
Explore how genetic testing unveils the links between Alzheimer Disease 19 and COVID-19, offering early diagnosis, personalized treatments, and targeted preventive strategies.
Explore how genetic testing aids in diagnosing Amelogenesis Imperfecta Type 2A5, focusing on RELT gene mutations for personalized care and informed family planning.
Explore ALS Type 19's genetic roots with insights on ERBB4 mutations. Learn how testing aids diagnosis, management, and research advancements in ALS.